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INTRODUCTION 
Urinary tract infection is the infection of the so called ’The Problem 
Tract’, that is the tract which goes down from the kidney to the urethra is one 
of the place where  infections are most common, next only to respiratory tract. 
The importance of the urinary tract infection is best realized, in the wake of its 
perilous complications. 
  Mostly bacterial infections are common. In that, urinary tract infection 
caused by occur more frequently in women more so in pregnant women due to 
normal functional changes and changes that change the morphology that takes 
place during pregnancy, in the genitourinary tract. UTI is divided into two 
types. It can be either symptomatic or asymptomatic. Early detecting and 
treating of ASB is of considerable importance to reduce the mortality and 
morbidity in the mother and offspring. 
Asymptomatic bacteriuria is commonly referred as significant 
bacteriuria in the non existence of any specific symptoms of infection. Its 
incidence is found to be in 2% - 10% of all pregnant women ( Whalley 1967 ). 
The previously defined criteria for labeling it as asymptomatic 
bacteriuria was the presence of  > 105 bacteria/ml in two clean catch samples 
taken on two consecutive days  (Kass 1960a). But then, the finding of  > 105 
bacterial/ml in a single voided midstream urine sample seems to be a 
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satisfactory as well as a  more practical alternative, although the chance that 
the woman has bacteriuria with single sample is only 80%. It increases to 95% 
if more than two consecutive cultures collected show the presence of the same 
organism (Kass 1960a).Though, in pregnancy, there are urine screening tests 
which detect rapidly, since the end results are not reliable, quantitative urine 
culture is always the gold standard for detecting asymptomatic bacteriuria. 
Bacteriuria which occurs in pregnancy has greater chances to end up in 
pyelonephritis in up to 40 percent of pregnant women than during  nonpregnant 
period. Pregnant women who had had asymptomatic bacteriuria(ASB) are also 
more likely to develop Hypertensive disorders of pregnancy, Anemia, Chronic 
renal failure and UTI postpartum if untreated. So the incidence of these deadly 
complications can be decreased by promptly diagnosing  asymptomatic 
bacteriuria during pregnancy and treating it early. 
Urinary tract infection can also result in increased rates of preterm 
labour, low birth weight babies, and increased perinatal mortality. Treating 
bacteriuria in pregnancy reduces the occurrence of these complications, thus 
preventing the long term sequel that follows asymptomatic baceriuria. 
 Screening for asymptomatic bacteriuria and prompt management of 
asymptomatic bacteriuria in pregnancy has become a standard protocol in  
modern obstetric care. 
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Treatment of bacteriuria alone prevents up to 80 percent of cases 
progressing  to pyelonephritis. Numerous studies have shown that single-dose 
antibiotic treatment for asymptomatic bacteriuria in pregnancy is as effective 
as long course treatments. Single-dose treatment, which is equally effective to 
long course treatment, also has the advantages of minimal medication, 
increased patient compliance, cost-effectiveness, reduced side-effects and 
increased safety. 
Considering the above factors, the present study is designed to analyse 
the prevalence of asymptomatic bacteriuria in pregnant women and the 
associated risk factors and to compare the efficacy of single dose to 
conventional treatment of asymptomatic bacteriuria. 
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REVIEW OF LITERATURE 
This is discussed under the following headings: 
x HISTORY 
x EPIDEMIOLOGY 
x EMBRYOLOGY OF URINARY TRACT 
x ANATOMY OF URINARY TRACT: 
x MORPHOLOGICAL AND FUNCTIONAL CHANGES TAKING 
PLACE IN THE URINARY TRACT IN PREGNANCY 
x PREDISPOSING FACTORS FOR ASYMPTOMATIC 
BACTERIURIA 
x NORMAL FLORA OF THE GENITOURINARY TRACT 
x URINARY TRACT INFECTIONS 
x MICROBIOLOGY 
x PATHOGENESIS OF URINARY TRACT INFECTION 
x COMPLICATIONS ASSOCIATED WITH ASYMPTOMATIC 
BACTERIURIA OF PREGNANCY 
x DIAGNOSIS 
x TREATMENT 
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HISTORY: 
In 1550 BC, Hearst Papyrus  stated “sending forth heat from the 
bladder” as a way to refer to the urinary tract infection1. 
Pasteur  (1863)  discovered  urine to be a  good  culture  medium  
for  bacterial growth and Roberts (1881) correlated the bacteria presence in 
the urine to the symptoms but very little progress was made in exploring 
this relationship until quantitative assessments of the number of bacteria in 
the urine of patients with urinary tract infection were carried out by Marple 
(1941), Barr and Rantz (1948) and Sanford et al (1956)2. 
In 1957, Kass, through his pioneer work in this field established the 
validity of quantitative urine culture and documented that significant 
bacteriuria can occur in the absence  of  symptoms  or  signs  of  UTI3,4.  
The  initial  observations  that  ASB contributes to chronic renal failure, 
hypertension, and toxemia of pregnancy, generated a series of population 
based screening programs for ASB5. 
HISTORY OF ORGANISMS ISOLATED COMMONLY IN 
ASYMPTOMATIC BACTERIURIA  
In    1885,    German    Pediatrician    Theodore    Escherichia    first  
identified E. coli. 
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In  1919, Castellani and Chalmers identified the genus Escherichia 
and defined the species type E. coli1. 
In 1983, Friedlander first isolated this bacillus from fatal cases of 
pneumonia, also known to cause UTI.1,6 
In 1880, Sir Alexander Ogston, a Scottish surgeon gave the name 
Staphylococcus.1 
In 1884, Rosenbach first described the genus as Staphylococcus and 
split the genus into two types of species, namely Staphylococcus aureus 
and Staphylococcus albus. 7 
In 1965, Baird-Parker, recognised the species Staphylococcus 
aureus, Staphylococcus epidermidis and Staphylococcus saprophyticus.1   
         In 1880, Sir Alexander Ogston, a Scottish surgeon gave the name 
Staphylococcus.1 
In 1965, Baird-Parker, recognised the species Staphylococcus 
aureus, Staphylococcus epidermidis and Staphylococcus saprophyticus.1 
EPIDEMIOLOGY: 
Asymptomatic   bacteriuria  results in various complications which 
affects the fetus and is one of the causes of medical complications of 
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pregnancy. In 1962 when pregnant women with bacteriuria were compared 
with pregnant women without bacteriuria, Edward Kass found that  6%  of  
antenatal  women  having  ASB  were associated  with  higher rates of 
delivery of premature babies  and perinatal mortality.8 
Prevalence of ASB in the obstetric population ranges from 3-10%.9 
The  prevalence  of  ASB  was  found  8.4%  in  a  study  in  
Vishakhapatnam, India during the year 1997 to 1999. Primigravida had 
highest percent culture positivity of 66.6%. This study, revealed that 
incidence increased as socio-economic status of the patients decreased and 
higher incidence was recorded in patients of lower age group (<20 years 
age group i.e. 71.42%).Most commonly, E. coli was the microorganism 
isolated (83.3%).10 
In a study in Nigeria, they found high incidence of bacteriuria during 
third trimester of pregnancy (21.9%) compared with that in the first 
trimester (77%) while the level in the second trimester was 22.5%. 
Staphylococcus aureus was the most frequent pathogen (41.3%).11 
Another study was done which identified the fact that prevalence of 
ASB in the diabetic antenatal women was 12.5% as compared to 5.9% of 
the normal pregnancies.12 
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A study conducted on 270 pregnant women found prevalence of 
ASB was 9.3% and sensitivity and specificity of leukocyturia as a 
screening test was 91.3% and 83.6%.13 
The  risk  of  ASB was found to be 0.8% in first trimester which 
increased  to 1.93% at term. So risk increases as pregnancy advances.14 
In a study performed  in Turkey, prevalence of ASB in the first 
trimester was 0.9%, in the second trimester was1.83% and in the third 
trimester was 5.6%.15 
In 1997, a study on pregnant women aged between 15-40 years 
showed E.coli was found in 46% followed by coagulase negative 
Staphylococci (33%) and Citrobacter freundii (8%). Anti-microbial 
susceptibility test revealed 91% of E.coli isolated was resistant to 
ampicillin and amoxycillin and 91% of them sensitive to nitrafurantoin.16 
One study to determine rates of occurrence of bacteriuria according 
to different races in London, demonstrated that, in the Caucasian group, 
the prevalence of bacteriuria was 6.3% and the prevalence is 2% for the 
Bangladeshi women.17 
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Another study which was done retrospectively in 24,000 births 
showed that the prevalence of bacteriuria in pregnancy was 28.7% in 
Whites and Asians, and 30% in Black and 41.1% in Hispanies.18 
The prevalence of ASB in a study at Iran on 1100 pregnant women 
was 6.1%. Maternal age was lower in the women with a positive urine 
culture (p=0.02). ASB did not have  any  significant  relation  with  the  
trimester  of  the  pregnancy  (p=0.53),  parity (p=0.84), the level of 
education (p=0.52) and the BMI (p=0.17).9 
A study by the ACOG showed that on comparing  different 
strategies of screening like leukocyte esterase-nitrite dipstick or urine 
culture and various treatment modalities it was concluded that culture 
techniques were not cost beneficial as compared to the dipstick 
technique.20 
A study at Middlesex, England  concluded that the conditions which 
favoured upon the cost effectiveness of screening for ASB in pregnancy 
was decided by the local population’s characteristics, and more specifically 
by the prevalence of ASB in pregnancy.21 
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EMBRYOLOGY OF URINARY TRACT:22 
 
UROGENITAL SYSTEM: 
Urogenital system is derived from the intermediate mesoderm, and 
the primitive urogenital sinus which is a part of cloaca. 
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KIDNEYS: 
Kidneys develop from two sources. The nephrons are derived from 
the metanephros. The collecting part is formed by ramification of the 
ureteric bud. 
URETER: 
Ureter arises from the ureteric bud. 
URINARY BLADDER: 
Urinary bladder is derived from the cranial part of the vesicourethral 
canal. Trigone epithelium is derived from absorbed mesonephric ducts. 
FEMALE URETHRA: 
The female urethra is derived from the primitive urethra and the 
pelvic part of the urogenital system. 
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ANATOMY OF URINARY TRACT: 
The urinary tract consists of kidney, urinary bladder, ureter and 
urethra 
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KIDNEYS: 
2 in numbers, it measures in dimensions in length 11cm, in breadth 6 
cm and thickness 3 cm. Left kidney is slightly longer and narrower than 
the right kidney. On an average it weighs 150 gms in males and 135 gms in 
females. Blood supply is by a pair of renal arteries from aorta. Venous 
drainage is by a pair of renal veins which drain into inferior vena cava. 
Lymphatic drainage is to lateral aortic lymph nodes. Nerve supply is by 
renal sympathetic plexus. 
URETERS: 
Each ureter is about 25 cms long- 10 inches. Half  of  the ureter- 5 
inches lies in the abdomen and half of the ureter- remaining 5 inches lies in 
the pelvis. In diameter, it measures about 3 cm. There are 3 constrictions in 
the ureter. Upper third of the ureter is supplied by renal arteries, and the 
middle third by testicular or ovarian artery and the last third by superior 
vesical artery. Venous drainage is by corresponding veins. Lymphatic 
drainage is to lateral aortic and  iliac nodes. Nerve supply is by renal, 
testicular or ovarian and hypogastric nerves. 
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URINARY BLADDER: 
It is a distensible organ which has varied size  and shape according 
to the amount of urine it contains. Branches of internal iliac artery-superior 
and inferior vesical arteries supply urinary bladder. Vesical venous plexus 
drain into the internal iliac vein. Lymphatic drainage is into the iliac nodes 
and from there to the para aortic nodes. Sympathetic and parasympathetic 
fibres from the inferior hypogastric plexus innervate the bladder. 
FEMALE URETHRA: 
Female urethra is 4 cm long and 6mm in diameter. Vesical and 
principally the vaginal artery supply the female urethra. Veins draining the 
urethra drain into vesical plexus of veins and the internal pudendal veins. 
Lymphatics drain into internal and external iliac nodes. Fibres supplying 
urethra come from inferior hypogastric plexus and the perineal branch of 
pudendal nerve. 
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MORPHOLOGICAL AND FUNCTIONAL CHANGES TAKING 
PLACE IN THE URINARY TRACT IN PREGNANCY:23 
ANATOMICAL CHANGES: 
KIDNEY- 
There is dilatation of the ureter and the renal pelvis. The kidneys 
enlarge in size by 1 cm. 
URETER- 
Ureters become atonic due to high progesterone level. Dilatation of 
the ureter above the pelvic brim with stasis is more marked on the right 
side especially in primigravida. It is due to dextrorotation of the uterus 
pressing the right ureter against the pelvic brim and also due to pressure by 
the right ovarian vein which crosses the right ureter at right angle. The 
stasis is more marked between 20-24 weeks. There is marked hypertrophy 
of the muscle and the sheath  of  the ureter specially of the pelvic part 
probably due to estrogen. There is elongation, kinking and outward 
displacement of the ureters. 
BLADDER- 
There is marked congestion and hypertrophy of  the muscles and 
elastic tissues of the wall. In late pregnancy, the bladder mucosa becomes 
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oedematous due to venous and lymphatic obstruction especially in 
primigravida following early engagement. Increased frequency of  
micturition is noticed at 6-8weeks of pregnancy which subsides after 12 
weeks. It may be due to resetting of osmoregulation causing increased 
water intake and polyuria. In late pregnancy, frequency of micturition once 
more reappears due to pressure on the bladder as the presenting part 
descends down the pelvis. Stress incontinence may be observed in late 
pregnancy due to urethral sphincter weakness. 
FUNCTIONAL CHANGES: 
Renal changes: 
Renal blood flow increases by about 80% by the second trimester, 
but falls in the third trimester. Therefore, there is corresponding increase in 
the glomerular filtration rate (50%), although less than the renal blood 
flow. Hence, creatinine clearance also increases. In pregnancy major 
changes in tubular reabsorption occurs. 
Serum creatinine: 
Serum creatinine levels fall in pregnancy as the renal clearance is 
inversely proportional to the plasma concentration. Levels above 0.8 mg/dl 
are suggestive of intrinsic renal disease. 
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Serum urea and uric acid: 
Serum urea and uric acid levels also decrease in pregnancy due to 
the increased renal clearance and defective tubular reabsorption. Normal 
levels are 15-20mg/dl. In late pregnancy, serum uric acid increases due to 
the decreasing GFR and due to the gradual increase in tubular 
reabsorption, but the level is always less than the normal values. 
Glycosuria: 
Glucose is completely reabsorbed in the non- pregnant state so that 
no glucose appears in urine in healthy individuals. In pregnancy, however 
many women with normal blood sugar may exhibit glycosuria. The 
remarkable increase in glomerular filtration along with the defective 
tubular reabsorption of glucose results in lowering of the renal threshold in 
pregnancy (normal is 180mg/dl) and this results in glycosuria without 
concomitant increase in blood sugar. 
Proteinuria: 
Proteinuria-5% of pregnant women may show orthostatic or postural 
proteinuria when the women is ambulatory. This is normal in the absence 
of renal disease. Significant proteinuria is abnormal and considered as 
more than 300mg in 24 hours. 
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PREDISPOSING FACTORS FOR ASYMPTOMATIC 
BACTERIURIA 
Sexual activity, increasing age, parity, sickle cell disease or trait 
(with associated  renal  parenchymal  damage), low socioeconomic status, 
a H/O of UTIs,  diabetes  mellitus  and anatomic  abnormalities  that  in  
both  the pregnant and non-pregnant state are associated with an increasing 
frequency of UTI.24 
Women at high risk for recurrent UTIs may be more genetically 
prone to recurrent infections because they have a high prevalence of the 
human leukocyte. 
Women of blood group B or AB who are nonsecretors of blood 
group substances are at significantly higher risk for developing infections, 
than are the women of other blood groups. In addition, patients with Lewis 
blood group types who are considered secretors have a lower incidence of 
urinary tract infections.25 
In 1962, Tyagi, in his study found that 29.4% of primiparae and 
21.7% of multiparae had asymptomatic bacteriuria.26 
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In 1965, Kass EH, Savage WB, Santamarina BAG in their study 
found that bacteriuria was somewhat more common among blacks than 
among whites. 
In 1967, Savage et al. found that the prevalence of bacteriuria 
increased with age by 1% to 1.5% per decade and that the frequency of 
bacteriuria was directly proportional to gravidity.27 
In 1974, Shanti Kumari Roy, GR Sinha, M Quadros in their study 
reported that the incidence of bacteriuria was found to increase slightly 
with increasing parity (11.6% in primigravidae as against 14.7% in grand 
multiparae) and the incidence of bacteriuria was found to be 10% in the 
first trimester to 13.1% in the third trimester. In their study they also found 
that 16.1% of 31 bacteriurics and 4.6% of 219 nonbacteriurics gave a past 
history of urinary tract infection.28 
In 1977, P Mitra, VA Kulkarni, SR Sengupta et al. in their study 
found that the total incidence of bacteriuria was 10.3%, 6% at 28 weeks of 
gestation, with 4.5% developing bacteriuria at 36-38 weeks of pregnancy. 
27.3% of bacteriuric patients belonged to < 20 years age group, 68.2% of 
bacteriuric patients belonged to 20 to 30 years and 4.5% of bacteriuric 
patients belonged to more than 30 years age group. 
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40.9% of bacteriuric patients were primigravidae, 11.36% were first 
para, 36.3% were second para and 11.36% were of third or more parity.29 
In 1982, PK Chng and Marion H Hall found that on comparing the 
relation of ASB to previous history of UTI, 50 (23.6%) of the 212 women 
who had bacteriuria had a past history which had been compared with 311 
(19.7%) of the 1575 women who did not have bacteriuria.30 
In 1987, P Yashodhara, Rita Mathur and Leela Raman, in their study 
reported that  ASB  was  found  in  7.73  percent  of  pregnant  women  
belonging  to  the  low socio-economic status group and 10.5 percent of the 
women belonging to upper income group. In the low income group, 3.88% 
belonged to 19 years age group, 8.8% to 20-28 years age group and 8.1% 
to 29 years age group. 4.26% were primigravidae, 8.33% were first para, 
10.2% were second para and 8.28% were    third para. 9.68% of 
bacteriuric patients belonged to   12 weeks gestation, 7.6% to 13-28 
weeks and 7.7% to > 29 weeks gestation. 
In the higher income group, 17.14% belonged to 19 years age group, 
8.96% to 20-28 years age group and 11.1% to 29 years age group. 13.56% 
were primigravidae, 8.57% were first para and 8.51% were second parae, 
5.5% of bacteriuric patient belonged to  12 weeks gestation, 8.57% to 13-
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28 weeks and 12.72% of bacteriuric patient belonged to > 29 weeks 
gestation.31 
In 1996, G Nath, M Chaudhary, Jai Prakash, et al. in their study 
found that 5.26% of bacteriuric women belonged to < 25 years age group, 
10.36% to 25-29 years group and 12.43% to   30 years age group. Third 
trimester was associated with highest number of cases (11.9%), followed 
by second (7.5%) and first (5.7%). Primigravidae had higher number of 
culture positivity with significant bacteriuria (11.47%) than multiparous 
women (7.04%). They have also stated that the prevalence of ASB depends 
among other factors on the socioeconomic status of the population.32 
In 1997, A.B. Maclean has stated that the incidence had an increase 
with in age and gravida and that it was higher in patients belonging to low 
socio-economic groups.33 
In 1999, Maria C Savoia has stated that incidence of bacteriuria in 
pregnancy was found to  increase with age, sexual activity, parity and 
socioeconomic status. Also it stated that the prevalence was higher in 
subgroups who were diabetics, around 12.5% and in those who had a 
history of prior UTI it was 18.5%.34 
In  2002,  SV  Lavanya  and  D  Jogalakshmi  in  their  study  found  
that  the incidence was higher in less than 20 years age groups, i.e. 71.42%, 
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66.6% of the cases were primigravida, 7.2% were first para, 9.6% were 
second para and 16.6% were multiparous. Their study also revealed that 
the incidence increased as socio-economic status of the patients 
decreased.35 
In 2003, Deborah A Wing has stated that prevalence of ASB in 
pregnancy is 2-10%  and  is  influenced  by  socioeconomic  status,  parity,  
age,  sexual  practice, diabetes mellitus and sickle cell anaemia.36 
NORMAL FLORA OF THE GENITOURINARY TRACT:37 
           Mycobacterium smegmatis, a harmless commensal, is found in the 
smegma of the genitalia of both men and women. This may cause 
confusion by its presence in the voided specimens of urine. The female 
urethra is generally sterile. Sometimes the female urethra contains a few 
Gram positive cocci. 
          The vulva of the newborn child is sterile but after 24 hours it 
acquired a varied flora of nonpathogenic organisms from the skin,vagina 
and intestines. The nature of  the flora in the vagina depends on the pH of 
its secretions and its enzyme content. 
           In the first 24 hours it is invaded by micrococci, enterococci and 
diphtheroids. In 2-3 days, the maternal estrin induces glycogen deposition 
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in the vaginal epithelium. This facilitates the growth of a lactobacillus 
namely Doderlien’s bacillus which produces acid from glycogen, and the 
flora for a few weeks is similar to that of  the adult. After the passively 
transferred estrin has been eliminated in the urine, the glycogen disappears, 
along with Doderlien’s bacillus and the pH of the vagina becomes alkaline. 
This brings about a change in the flora to micrococci, alpha and non 
hemolytic streptococci, coliforms and diphtheroids. 
           At puberty, the glycogen reappears and the pH changes to acid due 
to the metabolic activity of Doderlien’s bacilli, E.Coli and yeasts. This 
change probably helps in the prevention of colonization by possible 
harmful micro organisms. 
          During pregnancy there is an increase in Staphylococcus 
epidermidis, Doderlien’s bacilli and yeasts. Occasionally other members of 
the intestinal flora may be  present. 
          After menopause, the flora resembles that found before puberty. 
           The normal vaginal flora often includes anaerobic cocci and bacilli, 
listeria, anaerobic streptococci, mimeae, mycoplasma, Gardnerella 
vaginalis, neisseriae and spirochetes. 
24 
 
URINARY TRACT INFECTIONS:38 
 
Acute infections of the urinary tract 
 
Lower urinary tract infection                                        Upper urinary tract 
infection 
(urethritis and cystitis)                (acute pyelonephritis,intra renal,  
       perinephric abscess) 
          Infections of the urethra and bladder are often considered superficial 
or mucosal infectons, whereas pyelonephritis and renal suppuration are 
considered to be tissue invasion. 
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           Urinary tract infection is said to be present pathogenic micro 
organisms are found to be detected in the urine or in the urinary tract-
kidney, urethra or bladder. 
Urinary tract infection 
                                                                                                            
                  Symptomatic                                                 Asymptomatic 
           In most cases, the presence of > 105 organisms/ milliliter in a mid 
stream “clean catch” sample of urine indicates infection of the urinary 
tract. So the presence of  >105 micro organisms in a urine sample is called 
significant bacteriuria. 
           Symptoms accompanied by significant bacteriuria is symptomatic 
urinary tract infection. 
           Only significant bacteriuria without any symptoms is asymptomatic 
urinary tract infection. 
          Symptoms such as dysuria, urgency of micturition, frequency of 
micturition,lower abdominal pain and sometimes fever that are not 
associated with significant bacteriuria has been given the term “acute 
urethral syndrome”. 
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          Pyelonephritis denotes bacterial infection of the kidney. This is 
believed to result from interstitial nephritis. Sometimes non infectious 
causes may result in a similar picture as of chronic pyelonephritis which is 
indistinguishable pathologically from chronic pyelonephritis. 
MICROBIOLOGY:38 
 The aetiologic agents associated with Bacteriuria in pregnancy as 
well as in non-pregnant state is caused by similar causative organisms. The 
length of the urethra in female is relatively lesser. This predisposes to 
frequent colonization with organisms that colonize the gastro intestinal 
tract. 
 Bacteriuria with symptoms and also without symptoms is most 
commonly caused by E. coli. The association of  E.Coli is regarded 
significant. This represents about 70% to 80% of isolated micro organisms. 
CLED medium showing pink semi translucent colonies of E.Coli 
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Proteus, Klebsiella and rarely enterobacter species which are gram 
negative organisms form the cause of a minority of urinary tract infection 
which is not complicated. Much importance is attributed to all the above 
mentioned organisms including Serratia species and Pseudomonas species 
in playing a role in repeated infections of urinary tract and also in urinary 
tract infections in association with renal stones, any block in the urinary 
tract and urological manipulations.  
CLED medium showing blue green semitranslucent colonies of 
Proteus mirabilis 
 
Urinary tract infections are less commonly caused  by Gram positive 
cocci. But, younger female patients, 10-15% of urinary tract infections 
which present acutely is caused by Staphylococcus saprophyticus  species. 
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Enterococcus and Staphylococcus aureus play an impotant role in causing 
infections in women with renal stones and in those with previous 
instrumentation and previous surgeries. Staphylococcus epidermidis is 
mostly associated with catheter associated urinary tract infection. 
In women who have acute urinary symptoms , who present with 
pyuria, but sterile urine even in suprapubic aspiration collection of urine 
usually demonstrate organisms which are sexually transmitted urethritis 
producing agents like Chlamydia trachomatis as well as Neisseria 
gonorrhoeae and herpes simplex virus. 
Other unusual bacteria which have been isolated from pregnant 
women having symptoms of urinary tract infection or not, are Ureaplasma 
urealyticum as well as Mycoplasma hominis. 
Among viral infections, adenoviruses cause acute haemorrhagic 
cystitis in children and also in some young adults. Candida and other 
fungal species have been isolated from urine specimens of catheterized or 
diabetic patients. These may sometimes progress to symptomatic invasive 
infection. 
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PATHOGENESIS OF URINARY TRACT INFECTION:38,23 
Urinary tract is regarded as a continuous tract containing a column 
of  urine extending from urethra to the kidney. Urethra is the entry point 
for all infections of the urinary  tract. Pyelonephritis of  the kidney is 
caused by these infections which ascend from the bladder which had 
already gained entry through the urethra. 
In females the gram negative organisms which reside in the bowel 
colonize the vaginal introitus, periurethral skin and the lower urethra. So 
females are prone for cystitis. 
The factors favouring  peri urethral colonization in females are : 
1.Alteration of normal bacterial flora of vagina by antibiotics 
2.Genital infections 
3.Contraceptives 
4.Loss of  H2O2 producing lactobacilli which is normally dominant 
5.Urethral massage during intercourse 
Moreso pregnancy itself pose increasing risk for urinary tract 
infection. The risk is increased in pregnant women from 6 weeks to 24 
weeks of gestational period because almost in each one of  antenatal 
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women, the ureter is dilated and this dilatation is the same till labour. This 
is being referred by the term-“hydronephrosis of pregnancy”. 
Factors predisposing to upper tract infection in pregnancy : 
x Bladder volume is increased  
x Bladder tone is decreased 
x Ureteral tone is decreased 
x Ureteral peristalsis is decreased 
x Temporary incompetence of the vesicoureteral valve 
 
Increased retention of urine 
 
Uretero vesical reflux 
  Added to this, there is functional rise in volume of plasma in 
pregnant women. This reduces concentrating ability and thus resulting in 
diluted urine. Furthermore in 70% of pregnant women develop glycosuria, 
where glucose in urine favours growth of bacteria in urine. 
There is a reduced resistance of the urinary bladder and urethra in 
pregnant women to the invasion of micro organism due to increased  
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progestin getting excreted in urine as well as due to estrogens. This 
reduced capacity is also due to decreased ureteral tone and may also be 
allow certain species of bacteria to growin a selective fashion. Thus the 
above mentioned factors favour the development of urinary tract infections 
during pregnancy. 
COMPLICATIONS ASSOCIATED WITH ASYMPTOMATIC 
BACTERIURIA OF PREGNANCY 
It is well established that ASB has serious outcomes in pregnancy. 
Pregnant women with asymptomatic bacteriuria have an increased risk of 
pyelonephritis and there is a strong association between ASB and preterm 
and low birth weight delivery. 
Other complications of pregnancy associated with bacteriuria such 
as anaemia, hypertension or long-term renal function impairment have also 
been documented. 
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COMPLICATONS ASSOCIATED WITH ASYMPTOMATIC 
BACTERURIA 
 
 
MATERNAL       FETAL 
1.Hypertensive disorders of pregnancy 1.Preterm birth 
2.Anemia    2.Low birth weight babies 
3.Progression to pyelonephritis   3.Increased perinatal mortality 
4.Chronic renal failure  
5.UTI postpartum 
In 1960, Kass has shown that 40 percent of patients with bacteriuria 
develop overt urinary tract infection.39 
Acute pyelonephritis 
Acute  pyelonephritis  can  be  described  as the  acute  bacterial  
infection of the kidney presenting with fever, and mostly flank pain. 
When concentrated, 20-40% of mothers with ASB will develop 
acute pyelonephritis. 
Non-pregnant women with ASB rarely develop pyelonephritis. 
Acute bacterial pyelonephritis is frequent in pregnant women and occurs in 
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1-4% of all pregnant women (Kass, 1973). Of the women who develop 
pyelonephritis during pregnancies, 60-75% acquires it during the third 
trimester. Women with persistent bacteriuria may have increased incidence 
of impaired creatinine clearance and urinary concentrating ability. 
The mechanisms of the impairment may be due to direct 
involvement of the renal concentrating mechanisms by infection, an 
increase in the hydronephrosis of pregnancy due to infection and 
malfunction of the ureters and changes in the concentrating mechanism 
secondary to slight reductions in the GFR. 
The marked dilatation of the ureters during the later stages 
apparently allows bacteria   in   the   bladder   to   reach   the   upper   tract   
and   to   produce   symptomatic pyelonephritis. Over 75% of the cases of 
acute pyelonephritis can be prevented by eliminating asymptomatic 
bacteriuria in the early stages of pregnancy. Kass in 1959 reported  that  
there  was  an  association  between  ASB  and  prematurity  and  that  the 
eradication of bacteriuria significantly reduced the rate of premature 
delivery. 
In  a  study  at  WHMC,  it  was  found  that  the  annual  incidence  
of  acute pyelonephritis decreased from 4% to 0.8% and this decrease 
correlated with the eradication of ASB. 
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A sharp reduction in the annual incidence of pyelonephritis (1.8% to 
0.6%) occurred in an another study after the introduction of a program to 
screen and treat ASB among pregnant women. 
As early as in 1976, Eschenbach has stated that acute pyelonephritis 
is an important and serious complication of pregnancy which usually 
develops in women with ASB.40 
Preterm labour and low-birth weight 
Antepartum urinary tract infection has also been implicated as a risk 
factor for adverse perinatal outcomes like premature birth with and/or 
LBW and perinatal death. 
In the pre-antibiotic era itself, it was well documented that 
pyelonephritis of pregnancy was associated with preterm delivery was well 
known. The rate of pre maturity can be as high as 20-50%. In general, it 
seems that pre maturity and LBW are increased in patients refractory to 
multiple courses of therapy. They have been reported to have a 
significantly LBW infants than in those who responded. 
In a meta-analysis it was proven that if ASB in pregnancy was not 
treated, it resulted in higher rates of LBW and preterm delivery. 
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The mechanism by which ASB promotes preterm labour is not clear, 
but subclinical amnionitis or phospholipids A2 production by bacteria have 
been proposed. 
In another study, LBW newborns and small for gestational age 
newborns were respectively 2.04 and 1.57 times more frequent in UTI 
associated pregnancies compared to controls. 
Incidence  of  prematurity  was  75%  and  that  of  LBW  was  50%  
in  untreated patients of ASB in a study in India. 
In 1992, Robert Mittendorf, Michelle A Williams and Edward H 
Kass have reported from their meta analytical study that bacteriuric 
mothers were found to have a 54% higher risk of giving birth to LBW 
infants and twice the risk of giving birth to a preterm infant than non 
bacteriuric mothers.27 
Associations have been documented between antepartum UTI and 
variety of maternal complications of pregnancy, including hypertension/ 
preeclampsia, anaemia, amnionitis and endometritis, long-term renal 
function impairment.. 
36 
 
In 1994, Schieve and colleagues, in their study reported increased 
risks for low birthweight, preterm delivery, hypertension or preeclampsia 
and maternal anaemia.41 
In 2001, Larry C Gilstrap III and Susan M Ramin have stated that 
failure to treat bacteriuria during pregnancy may result in as many as 25% 
of women experiencing acute pyelonephritis and women having acute 
pyelonephritis might end up in certain consequences, like premature 
delivery, renal  failure, Acute Respiratory Distress Syndrome, sepsis, 
shock, and haematologic abnormalities.42 
In 2002, Richard L Sweet and Ronald S Gibbs have stated that 
untreated ASB during pregnancy often leads to acute pyelonephritis in 
20% to 30% of cases.4 
There is an association between maternal UTI and foetal death and 
mental retardation or developmental delay. Glial cells are either destroyed 
or transformed by endotoxin can lead to perinatal leukoencephalopathy and 
death. The probability of women with untreated UTI having a child with 
mental retardation or developmental delay was 35% higher than the 
unexposed group. 
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DIAGNOSIS: 
In 1941, Marple pointed out that colony counts were imperative in 
order to differentiate contamination from significant bacteriuria and 
introduced the pour-plate technique for the quantitative culture.3 
Pour – plate method 
 
In 1962, Simmons and Williams introduced TTC (Triphenyl 
Tetrazolium Chloride) test.43 
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Triphenyl Tetrazolium Chloride test 
 
The semi quantitative bacteriological procedures most widely used 
were the standard loop technique of Guttmann and Stokes (1963) and the 
filter paper strip method of Leigh and Williams (1964).44 
Standard loop method 
E.coli colonies on blood agar 
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Standard loop method 
E.Coli colonies on MacConkey agar 
 
In 1989, Flangan et al. recommended screening by dipstick tests for 
nitrite and leukocyte esterase.45 
Dipstick tests for nitrite and leukocyte esterase 
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In 1990, Michael D.D. McNeely stated that urine analysis was the 
oldest of all clinical laboratory examination.46 
In 1996, Zion Hagay, Roni Levy, Avraham Miskin et al. stated that 
Uriscreen test (Catalase test) was a reliable alternative to culture screening 
of all pregnant patients.47 
Catalase test 
 
In 1998, Betty A Forbes, Daniel F Sahm, Alice S Weissfeld stated 
that many screening methods have been advocated for use in detecting 
bacteriuria and/or pyuria, and these include microscopic methods, 
colorimetric filtration, bioluminescence, electrical  impedence,  enzymatic  
methods,  photometric  detection  of  growth  and enzyme immune assay, 
automated and semiautomated systems.  
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Acute urinary tract infection is first diagnosed by clinical signs and 
symptoms with which it presents. 
The criteria commonly used to make the diagnosis of asymptomatic 
bacteriuria is the growth in solid culture of 100000 or more colonies(>105 
colony-forming units or CFU)by a single midstream catch technique. 
Some women have lower colony counts that probably reflect the 
efficacy of the bladder washout and bacteriuria should be suspected if the 
colony count is between 205 and 1005/ml. In these cases the urine analysis 
may be useful and if there are more than 10 leukocytes/ml or the dipstick 
reveals leukocyte esterase or nitrates, most likely the the patient has 
asymptomatic bacteriuria with a low colony count. A CFU of 205/ml is 
also diagnostic if the urine sample is obtained by catheterization. 
Screening for asymptomatic bacteriuria should occur at the first 
prenatal visit(Nicolle et al.,2005). The screening is done by culture of a 
urine specimen obtained by mid stream catch.A urine dipstick is not an 
adequate substitute for urine culture and has unacceptably high false 
positive and false negative results. A positive nitrate test is only given by 
enterobacteria that convert nitrate to nitrite and leucocyte esterase is 
positive only when significant pyuria is present.48 
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Unfortunately, screening only once early in gestation will not detect 
more than one-third of the women who will develop pyelonephritis. The 
detection rate increases with a second and even more with a third screening 
during pregnancy, but this is only justified in women at high risk for some 
of the complications associated with bacteriuria, such as preterm labor. 
SPECIMEN COLLECTION: 
As of date, no recommended method has been reported for 
collecting urine as a specimen. Standard technique that is approved is to 
first clean the perineum and urethra and then mid stream urine voided in 
clean conditions is collected. But there are not enough evidence to support 
that this technique will reduce contamination and moreover it is not cost-
effective. 
Urine specimen can be collected by the following methods:49 
x Mid stream urine 
x Catheter collection 
x Suprapubic aspiration 
MID STREAM URINE: 
Urine samples are usually collected by the clean catch technique by 
obtaining the mid stream flow. First the periurethral area and the perineum 
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are cleansed with two to three washes with clear water, in a forward to 
backward motion. The labia should be held apart, if possible, during 
voiding. The first few millliters  of urine passed are discarded to flush out 
bacteria contaminating the urethra. This clean catch mid stream sample of 
urine is then collected in a wide mouthed sterile container that could be 
covered with a tightly fitted lid. 
CATHETER COLLECTION: 
Catheterization should best be avoided for obtaining urine sample as 
by catheterization for the purpose of screening asymptomatic bacteriuria, 
by itself, has a high risk of introducing nosocomial infection. Thus this 
method for collection of urine should be restricted only to those patients 
who are unable to void a midstream sample. However, it should be 
performed only with meticulous attention to aseptic technique. 
SUPRAPUBIC ASPIRATION: 
Though it is a cumbersome procedure, suprapubic aspiration is a 
method by which the urine is obtained by the most sterile technique. Here 
the urine is withdrawn directly by a sterile syringe through a needle which 
is inserted percutaneously, after  cleansing the area with sterile pad soaked 
in soapy water. This ensures collection of a contamination free sample. 
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SPECIMEN TRANSPORT: 
Since urine is an excellent supportive medium for the growth of 
most bacteria, when the sample is to be transported, the urine sample must 
be immediately refrigerated or preserved. Bacterial counts will remain 
constant in refrigerated urine for as long as 24 hours.49 
TREATMENT: 
Asymptomatic bacteriuria should be treated with antibiotics which 
have been found to be sensitive to the micro organism isolated. The 
antibiotic sensitivity has been detected by antibiotic susceptibility test 
(Kirby Bauer’s disc diffusion method). 
Antibiotic susceptibility test (Kirby Bauer’s disc diffusion method). 
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Drugs which act against specific organisms 
 Drug Organisms sensitive 
1 Amoxicillin Some E. coli, most Proteus spp., Group B 
Streptococci, Enterococcus spp., some 
Staphylococci spp. 
2 Amoxicillin – 
Clavulanic acid 
(Augmentin) 
Most gram negative aerobic bacilli and 
gram positive cocci 
3 Ampicillin Some E. coli, most Proteus species, group 
B Streptococcus, Enterococcus spp., some 
Staphylococci spp. 
4 Cephalexin Most E. coli, most Klebsiella and 
Proteus species, group B Streptococci, 
Staphylococci spp. 
5 Nitrofurantoin 
monohydrate 
macrocrystals – 
sustained release 
preparation 
Most gram negative aerobic bacilli 
6 Sulfisoxazole Most gram negative aerobic bacilli 
7 Trimethoprim- 
Sulfamethoxazole 
double strength 
Most gram negative aerobic bacilli 
 
Once bacteriuria is identified, antenatal women should be promptly 
treated. But certain antibiotics have a deleterious effects on the fetus.So 
their use is precluded for treating bacteriuria. These drugs are :  
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1. Tetracyclines - discolouration of fetal teeth and bony defects, 
congenital defects 
2. Quinolones - congenital deformities 
3. Trimethoprims, early in pregnancy -facial dysmorphisms, heart 
defects) 
4. Chloramphenicol and sulfonamides, late in pregnancy - Gray 
syndrome.50 
Antibiotics Dosage Drug Category in pregnancy 
Cephelexin 250 mg bd/qid B 
Erythromycin 250-500 mg qid B 
Nitrofurantoin 50- 100 mg qid B 
Sulfisoxazole 1g qid C 
Amoxicillin-clavulinic acid 250 mg qid B 
Fosfomycin One 3g sachet B 
Trimethoprim-
Sulfamethoxazole 
160/180 mg bd C 
 
From the beginning, the drug of choice had been ampicillin, but 
recently, E.Coli has been showing increased resistantce to ampicillin.11,12 
Nitrofurantoin is a good choice because of its high concentration in urine. 
Treatment for 10 days with 100 mg nitrofurantoin at bedtime is usually 
effective. Alternatively cephalosporins can also be used. 
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An antibiotic given for 7 to 10 days for treating asymptomatic 
bacteriuria is generally enough to eradicate the causative organisms, 
although shorter courses have been described with conflicting results. 
One of the most commonly used is nitrofurantoin, 100 mg orally twice 
daily for 3-7 days. Trimethoprim-sulfamethoxazole (one tablet orally twice 
a day, single or double strength for 3 days), amoxicillin (500 mg orally 
three times a day for 3-7 days), amoxicillin-clavulanate (500 mg orally 
twice daily for 3-7 days), and cephalexin (500 mg orally twice daily for 3-
7 days) can be used with similar success. However, resistance to 
amoxicillin and sulfonamides is common and it is better to select a drug 
after determining the antibiotic sensitivity of the bacteria. 
Masterton showed a cure rate of 88% using a single dose of 
ampicillin, 3 g in isolates which were ampicillin- sensitive. Many other 
studies reported that a single dose regimen using amoxicillin, cephelexin or 
nitrofurantoin was found to have a lesser success rate of 50 – 78% to 
eradicate bacteriuria in pregnancy. Fosfomycin which is available as 3 g 
sachet is found to be effective as a single dose.50 
The success of treatment should  be affirmed by a repeat culture of 
urine one week after finishing  treatment and the sterility of urine 
confirmed by monthly cultures during the pregnancy. The recurrent rate for 
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all the regimens is about 30%. Their failure to eradicate bacteriuria may 
indicate underlying upper UTI and need for longer therapy. Nitrofurantoin 
100 mg daily for 21 days has been found to be effective for treatment 
failures. For women with bacterial persistence or recurrence, suppressive 
therapy for remainder of the pregnancy with nitrofurantoin 100 mg daily 
may be advised. Continuous daily treatment is also necessary for patients 
who have relapses following successful treatments or who are reinfected 
by a different bacterial species. 
Villar et al conducted the The Cochrane Review to compare the 
efficacies of various durations for treating asymptomatic bacteriuria. 
Finally he came to a conclusion that enough evidence was not available to 
prove if a single-dose and multi-doses were the same in the treatment of 
asymptomatic bacteriuria. 
The relative risk was calculated to assess if the treatment failure for 
asymptomatic bacteriuria was more for single dose treatment compared to 
multi dose treatment (RR 1.25, 95% CI 0.93, 1.67). But even then there 
was no statistical difference. Single-dose treatment showed reduced 
incidence of adverse-effects, however (RR 0.52, 95%CI 0.32,0.85). 
Current recommendation is that conventional treatment regimens 
should be utilized for treating asymptomatic bacteriuria during pregnancy 
(Cochrane review). 
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Oral Antimicrobial Agents used for treatment of pregnant women 
with Asymptomatic Bacteriuria51 
Single- dose treatment 
 Amoxycillin 3 g 
Ampicillin 2 g 
Cephalosporin 2 g 
Nitrofurantoin 200 mg 
Trimethoprim-sulfamethoxazole 320/1600 mg 
3-day course 
Amoxicillin 500 mg three times daily 
Ampicillin 250 mg four times daily 
Cephalosporin 250 mg four times daily 
Ciprofloxacin 250 mg twice daily 
Levofloxacin 250 mg daily 
Nitrofurantoin 50 to 100 mg four times daily; 100 mg twice daily 
Trimethoprim-sulfamethoxazole 160/800 mg two times daily 
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Other 
Nitrofurantoin 100 mg four times daily for 10 days 
Nitrofurantoin 100 mg twice daily for 7days 
Nitrofurantoin 100 mg at bedtime for 10 days 
Treatment failures 
Nitrofurantoin 100 mg four times daily for 21 days 
Suppression for bacterial persistence or recurrence 
Nitrofurantoin 100 mg at bedtime for remaining period of pregnancy 
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AIMS OF THE STUDY 
x To study the prevalence of asymptomatic bacteriuria in antenatal 
women attending antenatal clinic in Government Kilpauk Medical 
College Hospital. 
x To study the association of the following risk factors in 
asymptomatic bacteriuria 
1. Age 
2. Gravida 
3. Socio economic status 
4. Trimester 
5. Past H/O UTI 
x To compare the effectiveness of the single dose antibacterial 
treatment with multidose treatment for asymptomatic bacteriuria 
during pregnancy 
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MATERIALS AND METHODS 
` Ethical committee clearance obtained in February 2011 
` Study design - prospective randomized controlled trial 
` Place of study - Antenatal op in KMCH 
` Duration of study - June 2011 to September 2012 
` Sample size – 310 calculated by the formula 
n = z21-Į/2 P (1-P) / d2  
n-sample size 
z-table value (1.96) 
P-prevalence 
d-constant (0.05) 
` 310 women with asymptomatic bacteriuria is divided equally into 
155 for both treatment groups. 
INCLUSION CRITERIA: 
1) All antenatal women irrespective of gestational age without  any 
symptoms of urinary tract infection. 
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EXCLUSION CRITERIA: 
1)  Antenatal women with symptoms of  UTI. 
2)  Antenatal women who were and are on antibiotics for any cause . 
3)  Presence of renal abnormalities. 
4) Presence of renal calculi. 
METHOD OF COLLECTION OF DATA 
All antenatal women attending antenatal clinic in Government 
Kilpauk Medical College Hospital for a routine check up and those who all 
fall in the inclusion criteria will be asked to collect a sample of clean catch, 
midstream urine in sterile wide mouthed containers with lid.  
The sample is sent for culture and sensitivity to the laboratory. 
Standard procedures are used to identify the micro organism grown 
in the culture in significant number. Then the sensitive antibiotic is 
obtained by subjecting them to antibiotic susceptibility test (Kirby Bauer’s 
disc diffusion method). After detection of asymptomatic bacteriuria, a 
course of antibiotic treatment is given. Follow up is done and after 7 days 
of completing the treatment a repeat urine culture is done to know the 
response to the treatment. 
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ANALYSIS AND RESULTS 
PREVALENCE OF ASYMPTOMATIC BACTERIURIA IN 
PREGNANT WOMEN 
In a study population of  6000 antenatal women attending antenatal clinic, 
the prevalence of asymptomatic bacteriuria in pregnant women was found 
to be 310/6000, that is 5.16% which correlates with the normal incidence 
of 2-10% of asymptomatic bacteriuria in pregnancy. 
 
5.16%
94.84%
ASYMPTOMATIC BACTERIURIA IN 
PREGANT WOMEN
PRESENT
ABSENT
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA 
ACCORDING TO AGE WISE DISTRIBUTION 
 
1-(15yrs-20yrs)-67 
   2-(21yrs-30yrs)-180 
                                              3-(31yrs-35yrs)-38  
                                              4-(>35yrs)-25 
From the above data, it was found that 21.61% were in the age group 15-
20 yrs,58.06% were in the age group21-30 yrs,12.25% were in the age 
group 31-35 yrs and 8.06% were in the age group >35yrs. 
 
AGE DISTRIBUTION 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA 
ACCORDING TO AGE WISE DISTRIBUTION 
   DOSE  
   1-single 
dose 
2-multi 
dose Total 
AGE 
GROUP 
1-(15yrs-20yrs) Count 33 34 67 
% within 
DOSE 
21.3% 21.9% 21.6% 
% of Total 10.6% 11.0% 21.6% 
2-(21yrs-30yrs) Count 94 86 180 
% within 
DOSE 
60.6% 55.5% 58.1% 
% of Total 30.3% 27.7% 58.1% 
3-(31yrs-35yrs) Count 15 23 38 
% within 
DOSE 
9.7% 14.8% 12.3% 
% of Total 4.8% 7.4% 12.3% 
4-(>35yrs) Count 13 12 25 
% within 
DOSE 
8.4% 7.7% 8.1% 
% of Total 4.2% 3.9% 8.1% 
 
 
This table shows that women with asymptomatic bacteriuria, more 
commonly fall in the age group – 21- 30 yrs and constitute around 58.1%. 
According to Pearson Chi-Square test, p value is 0.553 
 
Age is considered to play an important role as a risk factor for 
asymptomatic bacteriuria. 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA 
ACCORDING TO AGE WISE DISTRIBUTION 
 
 
 
 
1-(15yrs-20yrs) 
2-(21yrs-30yrs) 
3-(31yrs-35yrs) 
4-(>35yrs) 
 
 
This graph shows that asymptomatic bacteriuria is more common in 
the age group – 21- 30 yrs. 
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Independent Samples Test 
  t-test for Equality of Means 
  
 
95% Confidence 
Interval of the 
Difference 
  Mean 
Difference 
Std. Error 
Difference Lower Upper 
AGE Equal variances 
assumed 
-.129 .612 -1.332 1.074 
Equal variances not 
assumed 
-.129 .612 -1.332 1.074 
 
 
 
 
 
 
 
 
 
 
 
 
Independent Samples Test 
  Levene's Test for 
Equality of Variances 
t-test for Equality of 
Means 
  
F Sig. t Df 
Sig. (2-
tailed) 
AGE Equal variances 
assumed 
.200 .655 -.211 308 .833 
Equal variances 
not assumed 
  -.211 307.575 .833 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA-SOCIO 
ECONOMIC STATUS WISE DISTRIBUTION 
 
No of women in socio economic classV - 190 
                                                             IV - 118 
                                                             III - 2 
                                                             II - 0 
                     I - 0                              
From the above data it was found that 61.29% of women in socioeconomic 
class V, 38.06% of women in socioeconomic class IV and 0.64%of women 
in socioeconomic class III had asymptomatic bacteriuria. This shows that 
asymptomatic bacteriuria is more prevalent in low socioeconomic status. 
 
 
SOCIOECONOMIC CLASS 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA-SOCIO 
ECONOMIC STATUS WISE DISTRIBUTION 
 
   DOSE  
   1-single 
dose 
2-multi 
dose Total 
S.E.STATUS Class III Count 1 1 2 
% 
within 
DOSE 
.6% .6% .6% 
% of 
Total 
.3% .3% .6% 
Class IV Count 59 59 118 
% 
within 
DOSE 
38.1% 38.1% 38.1% 
% of 
Total 
19.0% 19.0% 38.1% 
Class V Count 95 95 190 
% 
within 
DOSE 
61.3% 61.3% 61.3% 
% of 
Total 
30.6% 30.6% 61.3% 
 
It is demonstrated that 61.3% of women, who have been found 
tohave asymptomatic bacteriuria are from socio economic class V. 
According to Pearson Chi-Square test, p value is 1.0 
Lower socioeconomic status is a definite risk factor for 
asymptomatic bacteriuria 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA-SOCIO 
ECONOMIC STATUS WISE DISTRIBUTION 
 
 
 
3 -  Socioeconomic class III  
4 -  Socioeconomic class IV 
5 -  Socioeconomic class V 
It is clearly shown that asymptomatic bacteriuria is more common in low 
socioeconomic class. 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA- GRAVIDA 
WISE DISTRIBUTION 
 
     No of women who are Primigravida - 183 
                                          Second gravida - 87 
                                          Third gravida - 35 
                                          Fourth gravida-5 
 
Out of 310 antenatal women studied, 183 (59.03%) were found to be 
primigravida, 87 (28.06%) were found to be second gravida, 35 (11.29%) 
were found to be third gravida and 5 (1.61%) were found to be fourth 
gravida.  
GRAVIDA WISE DISTRIBUTION 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA- GRAVIDA 
WISE DISTRIBUTION 
 
   DOSE  
   1-single 
dose 
2-multi 
dose Total 
GRAVIDA 1 Count 92 91 183 
% within DOSE 59.4% 58.7% 59.0% 
% of Total 29.7% 29.4% 59.0% 
2 Count 44 43 87 
% within DOSE 28.4% 27.7% 28.1% 
% of Total 14.2% 13.9% 28.1% 
3 Count 15 20 35 
% within DOSE 9.7% 12.9% 11.3% 
% of Total 4.8% 6.5% 11.3% 
4 Count 4 1 5 
% within DOSE 2.6% .6% 1.6% 
% of Total 1.3% .3% 1.6% 
 
Primigravidas are more prone for urinary tract infection is decipherd 
from the table well. 
According to Pearson Chi-Square test, P value is 0.470. 
Highest number is found to be in primi gravida implying that 
asymptomatic bacteriuria is more common in primi gravida. 
Primigravida is considered to be a risk factor for asymptomatic 
bacteriuria 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA- GRAVIDA 
WISE DISTRIBUTION 
 
Primigravida - 1 
Second gravida - 2  
Third gravida - 3 
Fourth gravida – 4 
 
Asymptomatic bacteriuria is most common in primigravida. 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA-PARITY 
WISE DISTRIBUTION 
 
 
   DOSE  
   1-single 
dose  
2-multi 
dose Total 
PARA 0 Count 99 105 204 
% within DOSE 63.9% 67.7% 65.8% 
% of Total 31.9% 33.9% 65.8% 
1 Count 45 43 88 
% within DOSE 29.0% 27.7% 28.4% 
% of Total 14.5% 13.9% 28.4% 
2 Count 10 7 17 
% within DOSE 6.5% 4.5% 5.5% 
% of Total 3.2% 2.3% 5.5% 
3 Count 1 0 1 
% within DOSE .6% .0% .3% 
% of Total .3% .0% .3% 
 
Nulliparous women are more prone for urinary tract infection. 
According to Pearson Chi-Square test, p value is 0.626  
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA-PARITY 
WISE DISTRIBUTION 
 
 
Nulliparous women are more prone for urinary tract infection. 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA- 
TRIMESTER WISE DISTRIBUTION 
 
Number of pregnant women in First trimester - 68 
                                                  Second trimester - 144 
                                                  Third trimester - 98 
 
Out of 310 antenatal women studied, 68 (21.9%) were found to be in the 
first trimester, 144 (46.45%) were found to be in the second trimester, 98 
(31.61%) were found to be in the third trimester.  
 
TRIMESTER WISE DISTRIBUTION 
 
 
  
 
68 
 
PREVALENCE OF ASYMPTOMATIC BACTERIURIA- 
TRIMESTER WISE DISTRIBUTION 
   DOSE  
   1-single 
dose 
2-multi 
dose 
Total 
TRIMESTER 
 
 
 
1 Count 38 30 68 
% within 
DOSE 
24.5% 19.4% 21.9% 
% of Total 12.3% 9.7% 21.9% 
2 Count 64 80 144 
% within 
DOSE 
41.3% 51.6% 46.5% 
% of Total 20.6% 25.8% 46.5% 
3 Count 53 45 98 
% within 
DOSE 
34.2% 29.0% 31.6% 
% of Total 17.1% 14.5% 31.6% 
 
 
According to Pearson Chi-Square test, p value is 0.185 
 
Asymptomatic bacteriuria is found to be more common in the 
second trimester followed by third trimester and finally in the first 
trimester. 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA- 
TRIMESTER WISE DISTRIBUTION 
 
First trimester - 1 
Second trimester - 2 
Third trimester – 3 
Asymptomatic bacteriuria is found to be more common in the 
second trimester followed by third trimester and finally in the first 
trimester. 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA BASED ON 
PAST H/O OF UTI  
 
                             PAST H/O UTI PRESENT IN 210 
                             PAST H/O UTI ABSENT IN100 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA BASED ON 
PAST H/O OF UTI  
 
 
   DOSE  
   1-single 
dose 
2-multi 
dose Total 
PAST H/O UTI 0-absent Count 50 50 100 
% within 
DOSE 
32.3% 32.3% 32.3% 
% of Total 16.1% 16.1% 32.3% 
1-present Count 105 105 210 
% within 
DOSE 
67.7% 67.7% 67.7% 
% of Total 33.9% 33.9% 67.7% 
 
Women having recurrent urinary tract infection are more prone for 
asymptomatic bactriuria  
According to Pearson Chi-Square test, p value is 1. 
Past H/O of UTI is considered to be a significant risk factor for 
asymptomatic bacteriuria. 
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PREVALENCE OF ASYMPTOMATIC BACTERIURIA BASED ON 
PAST H/O OF UTI 
 
         
0 – no past H/O UTI 
1 – past H/O UTI present 
Aymptomatic bacteriuria is more common in women who are 
having a previous history of infection. 
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REPEAT URINE CULTURE IN BOTH-SINGLE DOSE REGIMEN 
AND MULTI DOSE REGIMEN 
 
   DOSE  
   1-single 
dose 
2-multi 
dose Total 
RPT URINE 
C/S 
0-No growth Count 97 113 210 
% within 
DOSE 
62.6% 72.9% 67.7% 
% of Total 31.3% 36.5% 67.7% 
1- Growth Count 58 42 100 
% within 
DOSE 
37.4% 27.1% 32.3% 
% of Total 18.7% 13.5% 32.3% 
 Total Count 155 155 310 
% within 
DOSE 
100.0% 100.0% 100.0% 
% of Total 50.0% 50.0% 100.0% 
 
In single dose regimen 62.6% showed no growth in repeat urine 
culture and 37.4% showed failure of treatment. 
In multi dose regimen 72.9% showed no growth in repeat urine 
culture and 27.1% showed failure of treatment. 
According to Pearson Chi-Square test, p value is 0.052 
Multi dose regimen is slightly more effective in treating 
asymptomatic bacteriuria. 
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REPEAT URINE CULTURE IN BOTH-SINGLE DOSE REGIMEN 
AND MULTI DOSE REGIMEN 
 
 
0 – no growth 
1 – presence of growth 
Treating bacteriuria plays a major role in eradicating infection. 
Moreover, multi dose regimen is more effective in treating 
bacteriuria  
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SIDE EFFECTS COMPARED BETWEEN MULTI DOSE 
REGIMEN AND SINGLE DOSE REGIMEN 
 
   DOSE  
   1-single 
dose 
2-multi 
dose Total 
SIDE 
EFFECTS 
0-absent Count 131 86 217 
% within 
DOSE 
84.5% 55.5% 70.0% 
% of Total 42.3% 27.7% 70.0% 
1-present Count 24 69 93 
% within 
DOSE 
15.5% 44.5% 30.0% 
% of Total 7.7% 22.3% 30.0% 
 Total Count 155 155 310 
% within 
DOSE 
100.0% 100.0% 100.0% 
% of Total 50.0% 50.0% 100.0% 
 
In single dose regimen 84.5% showed no side effects and 15.5% 
showed few side effects. 
In multi dose regimen 55.5% showed no side effects and 44.5% 
showed few side effects. 
According to Pearson Chi-Square test, p value is 0. 
Single dose regimen showed reduced incidence of side effects than 
multi dose regimen. 
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SIDE EFFECTS COMPARED BETWEEN MULTI DOSE 
REGIMEN AND SINGLE DOSE REGIMEN 
 
 
 
Dose : 1 – Single dose            2 – Multi dose 
Side effects: 0 – no side effects 
                     1 – presence of side effects 
In single dose regimen 84.5% showed no side effects and 15.5% showed 
few side effects. 
In multi dose regimen 55.5% showed no side effects and 44.5% showed 
few side effects. 
Single dose regimen is advantageous in having more safety. 
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DISCUSSION 
 
Asymptomatic bacteriuria in pregnancy should be given serious 
regards in terms of maternal and perinatal morbidity. This is a preventable 
cause by which maternal and perinatal morbidity can be reduced 
substantially. 
Hence, the present study is done to evaluate the effectiveness of 
single dose and multi dose regimens commonly used in the treatment of 
bacteriuria in pregnancy. The adverse effects of these regimens is also 
compared to know the treatment efficacy. 
The prevalence of  asymptomatic bacteriuria in pregnancy, the risk 
factors associated and their prevalence is also studied. 
The present study included a study group of 310 pregnant women 
which were randomized and divided equally into two groups, each 
comprising of 155 pregnant women. 
The results were compared with other studies which were already 
performed and discussed as follows. 
Percentage of asymptomatic bacteriuria in antenatal cases were 
found to be 10.3% in Mitra P.et al(1997), 11.8% in Chng P.K. et al.(1982), 
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6.8% in  Kriplani Alka et al.(1993), 4.7% in Gratacos Eduard et al.(1994), 
7.6% in Hagay Zion et al.(1996), 7.0%in Gebre-Selassie S.(1998), 8.4% in 
Lavanya S V et al.(2002), 10.0% in Priyadarshini Indira et al.(2004) and in 
our present study(2013) it is 5.16%. 
In our study, it was found that 21.61% were in the age group 15-20 
yrs, 58.06% were in the age group 21-30 yrs, 12.25% were in the age 
group 31-35 yrs and 8.06% were in the age group >35 yrs. The prevalence 
was found to be increased in 21-30 yrs age group. Similar results have 
been found by Lavanya et al (2002) and Hazhir (2007). But Kass reported 
an increase in incidence with age. 
Stenquist et al (1989) after screening 3254 antenatal women at 
Sweden came to a conclusion that the risk of bacteriuria in pregnancy 
increased with increase in gestational age from 0.8% in 12 weeks of 
gestation to 1.93% at term. In another study by Tugrul et al (2005), the 
incidence in first, second and third trimesters were 0.9%,1.83% and 5.6%. 
In a study in Nigeria,similar results were obtained. In our study, women in 
the second trimester formed the major group of 46.45% 
 In our study, 59.03% comprised of primgravidas which was found to 
be higher than other gravidas. Similar report was obtained by Lavanya et al 
(2002) . 
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 A study in Vishakapatnam, India revealed that the prevalence of 
asymptomatic bacteriuria increased as the socioeconomic status of the 
antenatal women decreased. In our study, maximum women who had 
asymptomatic bacteriuria belonged to socioeconomic classV(61.29%).This 
result correlated with studies of  Turk M et al.(1962) and Lavanya SV et 
al.(2002)  (66.66%). 
In our study, prevalence of asymptomatic bacteriuria in women with 
past H/O UTI was found to be 67.74%. This report correlated with studies 
by Chng PK et al.(1982) (23.6%), Maria SC (1999) (18.5%) and Roy SK 
et al(1974) (16.1%). 
Villar et al conducted the  Cochrane Review to compare the 
efficacies of various durations for treating asymptomatic bacteriuria. 
Finally he came to a conclusion that enough evidence was not available to 
prove if a single-dose and multi-doses were the same in the treatment of 
asymptomatic bacteriuria. 
 The relative risk was calculated to assess if the treatment failure for 
asymptomatic bacteriuria was more for single dose treatment compared to 
multi dose treatment (RR 1.25, 95% CI 0.93, 1.67). But even then there 
was no statistical difference. Single-dose treatment showed reduced 
incidence of side-effects, however (RR 0.52, 95%CI 0.32,0.85). 
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In our study the repeat culture showed growth in 37.4% of women who 
received single dose treatment and in 27.1% of women who received 
multidose treatment. This is similar to the report obtained previously 
stating that risk of failure is more in single dose treatment. 
Moreover side effects were found to be present in 44.5% of women 
receiving single dose and in 15.5% of women receiving multi dose 
treatment. This gives us a report that multi dose was associated with lesser 
adverse effects. 
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SUMMARY 
Considering the high incidence of asymptomatic bacteriuria, 
screening technique definitely has a place in routine antenatal check up. 
Moreover 25% of these women develop acute pyelonephritis, usually in 
the third trimester, if left untreated. 
Asymptomatic bacteriuria, if recurrent is associated with high 
incidence of urinary tract abnormality(20%), congenital or acquired. 
Ampicillins or cephalosporins are the usual drugs used in the 
treatmentof asymptomatic bacteriuria. Single dose therapy is also 
suggested. 
In this study, though the risk of failure in single dose therapy is 
more, it is comparable to multi dose therapy. Side effects which occur 
during single dose treatment is lesser in rate when compared to multi dose 
therapy, but the difference is not statistically significant. 
This study also revealed that 
1. The incidence of antenatal women attending antenatal clinic in 
Government Kilpauk Medical College having asymptomatic 
bacteriuria is 5.16%. 
2. It is more common in 21-30 yrs of  age group. 
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3. It is commoner in Primigravida and occurs more often in second 
trimester. 
4. It is more common in low socioeconomic status.61.29% of women 
were in socio economic class V.  
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CONCLUSION 
Asymptomatic bacteriuria is prevalent in around 2-10% of antenatal 
women. If it is left untreated, they progress to pyelonephritis late in 
pregnancy. So early detection and prompt treatment is very 
important.Moreover it also predisposes to complications like preterm 
labour and low birth weight infants. 
Treating asymptomatic bacteriuria with single dose regimen is 
almost the same as multi dose therapy, with only a small difference in the 
failure rate being higher in single dose regimen. The side effects between 
the two regimens did not show large statistical difference. Moreover there 
are advantages that, in single dose therapy, there is increased patient 
compliance, minimal medication, reduced cost and increased safety of the 
patients. 
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PROFORMA 
1.NAME:     OP NO:   
2.AGE: 
3.ADDRESS: 
4.INCOME:   OCCUPATION:   EDUCATION: 
5.GRAVIDA:        PARA:         LIVE:          ABORTION: 
6.LMP:                             EDD: 
7.TRIMESTER: 
8.PAST H/O UTI: PRESENT/ABSENT 
9.C/O LOWER ABDOMINAL PAIN: 
10.C/O DYSURIA: 
11.C/O BURNING MICTURITION: 
 12.C/O FREQUENCY OF MICTURITION: 
 13.URINE C/S- 
x ORGANISM: 
x SENSITIVE  TO: 
 14.ANTIBIOTIC GIVEN: 
15.DOSE AND DURATION: 
16.REPEAT  URINE C/S AFTER 1 WEEK-GROWTH:YES/NO 
17.SIDE EFFECTS: 
x YES-SPECIFY- 
x NO 
 
PAST H/O UTI DOSE RPT URINE C/S SIDE EFFECTS
0-ABSENT 1-SINGLE 0-NO GROWTH 0-NO
1-PRESENT 2-MULTIPLE 1-GROWTH 1-YES
1 Selvakumari 198 19 1 5 1 0 0 0 1 0 1 1 1
2 Vijaya 132 23 2 4 1 0 0 0 2 1 2 0 0
3 Sangeetha 1142 23 2 5 1 0 0 0 2 0 1 0 0
4 Dharani 140 17 1 4 1 0 0 0 3 1 2 1 1
5 Lalitha 1140 27 2 4 1 0 0 0 1 1 1 0 0
6 Vanitha 404 25 2 5 2 1 1 0 3 1 2 0 1
7 Lakshmi 9221 18 1 4 1 0 0 0 2 1 1 1 0
8 Renuka devi 411 26 2 5 2 1 1 0 1 0 2 0 1
9 Ratna 19647 21 2 5 1 0 0 0 1 1 1 0 1
10 Chitra 1587 20 1 4 1 0 0 0 2 1 2 1 1
11 Kuppammal 386 27 2 5 1 0 0 0 3 1 1 0 1
12 Latha 617 21 2 4 1 0 0 0 2 1 2 0 1
13 Kavitha 378 26 2 5 2 1 1 0 1 0 1 1 0
14 Vanthana 377 26 2 4 2 0 0 1 2 1 2 1 0
15 Revathy 293 31 3 5 1 0 0 0 1 1 1 1 0
16 Varalakshmi 361 25 2 5 1 0 0 0 2 1 2 0 0
17 Sasikala 4019 26 2 4 2 0 0 1 2 1 1 0 0
18 Sathya 4061 20 1 5 1 0 0 0 3 1 2 0 0
19 Ammu 347 36 4 4 2 1 1 0 2 1 1 0 0
20 Jeyanthi 339 23 2 5 1 0 0 0 3 1 2 1 0
21 Saraswathi 2068 19 1 5 1 0 0 0 2 1 1 0 0
22 Barkath 4881 26 2 5 2 1 1 0 1 0 2 1 0
23 Shanthi 1928 27 2 3 1 0 0 0 1 1 1 1 0
24 Deepa 1715 18 1 5 1 0 0 0 2 1 2 0 1
25 Uma prakash 1801 30 2 4 1 0 0 0 3 0 1 0 0
26 Vinitha 1915 29 2 4 2 1 1 0 1 0 2 0 1
27 Rebecca 8590 27 2 5 2 1 1 0 1 1 1 1 1
28 Hemavathy 1683 19 1 5 1 0 0 0 2 1 2 0 0
29 Hemalatha 1910 36 4 5 2 1 1 0 1 1 1 0 0
30 Shoba 9312 18 1 5 1 0 0 0 1 0 2 0 1
31 Yogalakshmi 2017 29 2 5 2 1 1 0 3 1 1 0 0
32 Komala 9640 28 2 4 1 0 0 0 1 0 2 1 0
33 Sudha 2069 27 2 4 2 1 0 0 2 1 1 1 0
34 Janaki 9540 19 1 5 1 0 0 0 3 1 2 0 0
GRAVIDA PARA LIVE
MASTER CHART
ABORTION
TRIM
ESTER
S.NO NAME
OP.
NO
AGE
AGE 
GROUP
S.E.
STATUS
35 Nasreen 9514 25 2 5 1 0 0 0 2 1 1 0 0
36 Anushya 9130 32 3 5 2 1 0 0 3 0 2 0 0
37 Panjavarnam 1810 37 4 4 4 3 3 0 1 1 1 1 0
38 Ranjani 1391 28 2 5 3 2 2 0 2 1 2 1 1
39 Sasikala 491 27 2 5 2 1 0 0 1 0 1 0 0
40 Uma 1747 22 2 4 1 0 0 0 1 0 2 0 0
41 Selvarani 1402 21 2 4 2 0 0 1 2 1 1 0 0
42 Tameen 1806 22 2 5 1 0 0 0 2 1 2 0 1
43 Kalpana 1403 33 3 4 2 1 1 0 3 1 2 0 0
44 Usha 1866 18 1 4 1 0 0 0 1 0 1 1 1
45 Naseema 1861 19 1 5 1 0 0 0 2 1 2 0 0
46 Deepika 1814 36 4 5 4 2 2 1 3 1 1 0 0
47 Amudha 284 20 1 4 1 0 0 0 1 1 2 0 0
48 Malliga 4632 20 1 5 1 0 0 0 2 1 1 1 0
49 Prema 2271 26 2 4 3 1 1 1 3 0 1 0 0
50 Uthra 247 28 2 5 3 1 0 1 1 0 2 0 1
51 Uma 3467 30 2 4 2 1 1 0 1 1 1 1 1
52 Julie 3580 18 1 5 1 0 0 0 2 1 1 0 0
53 Jothi 245 25 2 4 1 0 0 0 3 1 2 0 0
54 Vimala 242 19 1 5 1 0 0 0 1 0 1 0 0
55 Amudha 2997 37 4 4 2 1 1 0 2 1 2 0 1
56 Sandhya 191 27 2 5 1 0 0 0 1 1 1 0 0
57 Vandhana 138 17 1 5 1 0 0 0 3 0 2 1 1
58 Selvi 133 32 3 4 3 2 1 0 3 1 1 1 1
59 Rekha 2991 29 2 5 2 1 1 0 3 1 1 1 0
60 Dowlath 10610 22 2 5 1 0 0 0 2 1 1 0 0
61 Anusree 4205 17 1 5 1 0 0 0 1 0 2 0 0
62 Muthulakshmi 206 22 2 5 1 0 0 0 2 1 1 0 0
63 Deepa 202 18 1 4 1 0 0 0 1 0 2 1 1
64 Selvakumari 198 36 4 5 2 1 0 0 1 0 1 0 0
65 Deepa 406 20 1 5 1 0 0 0 2 1 1 1 1
66 Dowlath 10610 28 2 4 1 0 0 0 1 0 2 0 0
67 Durgadevi 417 31 3 5 1 0 0 0 1 0 1 0 0
68 Kanchana 4574 28 2 5 2 1 1 0 1 1 2 0 0
69 Dhanavalli 3980 20 1 5 1 0 0 0 2 1 1 0 0
70 Chaitanya 420 34 3 5 3 2 2 0 3 1 2 0 1
71 Subadra 145 18 1 5 1 0 0 0 2 1 1 1 0
72 Kanmani 859 36 4 4 2 0 0 1 1 0 2 0 0
73 Mathi 30595 23 2 5 1 0 0 0 2 1 1 0 0
74 Sasikala 412 19 1 5 1 0 0 0 2 1 2 0 0
75 Rajeshwari 456 23 2 5 2 1 0 0 3 1 1 1 1
76 Kokila 8246 22 2 5 1 0 0 0 1 0 1 0 0
77 Saraswathi 357 22 2 4 1 0 0 0 3 1 1 0 0
78 Dhanalakshmi 7573 20 1 5 1 0 0 0 3 1 2 0 1
79 Muniyammal 467 32 3 5 2 1 1 0 2 1 2 1 0
80 Varalakshmi 479 20 1 4 1 0 0 0 1 0 1 0 0
81 Rekha 1477 23 2 5 2 0 0 1 2 1 2 0 1
82 Kalyani 482 22 2 5 1 0 0 0 1 1 1 1 0
83 Vanita 483 18 1 5 1 0 0 0 2 1 2 0 0
84 Chitra 4265 26 2 5 2 1 1 0 3 1 1 1 0
85 Deepa 4556 36 4 5 2 1 0 0 1 0 2 0 0
86 Vandhani 377 20 1 5 1 0 0 0 2 1 2 0 0
87 Famidha 4548 33 3 4 2 1 1 0 1 0 1 0 0
88 Dimple 4676 21 2 5 1 0 0 0 2 1 2 1 1
89 Sasikala 490 19 1 4 1 0 0 0 2 0 2 0 0
90 Sarala 5052 23 2 5 1 0 0 0 1 0 1 0 0
91 Manimegalai 513 30 2 4 2 1 1 0 1 0 2 0 1
92 Sumathy 790 22 2 5 1 0 0 0 3 1 1 1 0
93 Saranya 806 24 2 4 2 0 0 1 1 0 2 0 0
94 Shanthi 808 18 1 5 1 0 0 0 1 0 1 0 0
95 Lalitha 801 25 2 5 3 0 0 2 2 0 2 1 0
96 Kuppamma 3113 32 3 4 2 1 1 0 2 1 1 0 0
97 Lakshmi 5020 22 2 5 1 0 0 0 2 1 2 0 0
98 Anastasia 4205 28 2 4 1 0 0 0 3 1 1 1 1
99 Navaneedam 1319 26 2 5 2 1 1 0 3 1 2 0 1
100 Valarmathi 756 36 4 5 2 1 1 0 1 0 1 1 0
101 Umar fathima 766 24 2 5 1 0 0 0 3 1 2 1 0
102 Firdosh begam 4843 23 2 4 1 0 0 0 2 1 1 0 0
103 Suseela 853 20 1 5 1 0 0 0 1 0 2 0 0
104 Jabunisha 94 21 2 5 1 0 0 0 2 0 1 1 1
105 Uma devi 812 22 2 4 1 0 0 0 3 1 2 1 1
106 Sandhya 851 30 2 5 2 1 1 0 3 1 1 1 0
107 Revathy 143 20 1 5 1 0 0 0 1 0 2 0 0
108 Bhuvaneswari 847 31 3 5 2 1 1 0 3 1 1 0 0
109 Mala 173 24 2 5 1 0 0 0 2 1 2 1 0
110 Devi 60 27 2 5 3 1 0 1 1 0 1 0 0
111 Alamelu 828 28 2 4 2 1 1 0 2 1 2 1 1
112 Manonmani 623 19 1 4 1 0 0 0 1 0 1 1 1
113 Devaratchaki 199 25 2 5 1 0 0 0 2 1 1 0 0
114 Usharani 823 32 3 4 2 0 0 1 3 0 2 0 0
115 Julie nithya 266 20 1 5 1 0 0 0 2 1 1 1 1
116 Jeyakodi 267 24 2 4 1 0 0 0 1 1 2 0 0
117 Meera 178 23 2 5 1 0 0 0 2 0 1 0 0
118 Selvi 820 33 3 5 2 1 0 0 1 0 2 1 1
119 Prema 230 21 2 5 1 0 0 0 1 1 1 1 0
120 Velankani 4129 29 2 5 2 1 1 0 2 0 2 0 1
121 Kowsalya 414 28 2 5 1 0 0 0 1 0 1 1 1
122 Malathi 1021 19 1 4 1 0 0 0 2 1 2 0 1
123 Chitra 634 37 4 4 4 2 1 1 1 0 1 0 0
124 Buveshwari 4465 25 2 5 1 0 0 0 3 1 2 0 1
125 Ambika 1254 34 3 4 3 0 0 2 1 0 1 1 1
126 Meena 483 22 2 4 1 0 0 0 2 1 2 0 1
127 Samundiswari 380 32 3 5 2 1 1 0 3 0 1 0 0
128 Karpagam 4846 18 1 5 1 0 0 0 3 1 2 0 1
129 Kavitha 911 33 3 5 2 1 1 0 3 1 1 1 0
130 Deviarasi 898 24 2 5 1 0 0 0 2 1 2 0 1
131 Lavanya 942 34 3 4 3 2 2 0 3 1 1 1 0
132 Rani 939 19 1 4 1 0 0 0 2 1 2 0 0
133 Maragatham 924 23 2 5 1 0 0 0 3 0 1 0 0
134 Kanchana 942 35 3 4 1 0 0 0 2 1 2 0 1
135 Meera 178 23 2 5 1 0 0 0 3 1 1 1 0
136 Nandhini 1842 28 2 5 1 0 0 0 3 0 2 1 1
137 Fathima 2482 27 2 5 2 1 1 0 2 1 1 0 0
138 Radha 8759 35 3 4 1 0 0 0 3 1 2 1 1
139 Bhavani 2932 26 2 4 3 2 1 0 1 0 1 1 0
140 Thenmozhi 245 23 2 4 2 1 0 0 3 0 2 0 0
141 Jeyanthi 339 23 2 5 1 0 0 0 3 0 1 0 0
142 Eshwari 338 22 2 4 1 0 0 0 3 1 1 1 1
143 Muthukutti 334 27 2 4 2 1 1 0 1 0 2 0 1
144 Mohana 331 36 4 5 2 1 0 0 3 1 1 0 0
145 Poongathai 335 23 2 4 1 0 0 0 3 1 2 0 1
146 Sharmila 313 27 2 5 2 1 1 0 2 0 1 0 0
147 Yasodha 3386 32 3 5 1 0 0 0 2 1 2 0 0
148 Vijaya 4106 19 1 4 1 0 0 0 3 1 1 1 1
149 Revathi 293 33 3 5 2 1 1 0 3 1 2 0 1
150 Anish 292 25 2 5 1 0 0 0 2 0 1 0 0
151 Deivani 5107 25 2 5 1 0 0 0 2 1 2 0 1
152 Uma 302 27 2 5 2 1 1 0 3 1 1 1 0
153 Neela 282 25 2 4 1 0 0 0 2 1 2 0 1
154 Ramayee 284 19 1 5 1 0 0 0 3 1 1 0 0
155 Suganya 7354 20 1 4 1 0 0 0 3 1 2 0 1
156 Gnanaselvi 257 25 2 4 3 0 0 2 2 1 1 0 0
157 Amudha 2082 36 4 5 1 0 0 0 3 1 2 0 0
158 Karthiga 1659 20 1 4 1 0 0 0 2 1 1 1 0
159 Ambika 1653 21 2 5 1 0 0 0 2 0 2 0 1
160 Nadiya 1649 26 2 4 2 1 1 0 1 0 1 0 0
161 Dhakshayani 4682 22 2 5 1 0 0 0 2 1 2 0 1
162 Manjula 2312 30 2 4 2 1 1 0 3 1 1 1 0
163 Saritha 1560 29 2 5 3 2 1 0 2 1 2 0 1
164 Umarani 1010 19 1 4 1 0 0 0 2 1 1 0 0
165 Rajeshwari 1342 25 2 4 1 0 0 0 3 1 2 1 1
166 Jayachitra 348 31 3 5 1 0 0 0 2 1 1 0 1
167 Dharani 2537 24 2 4 3 0 0 2 3 0 2 0 1
168 Sathya 1572 29 2 5 2 1 0 0 3 1 1 0 0
169 Anjani 1619 19 1 4 1 0 0 0 3 1 2 0 0
170 Meena 178 28 2 4 2 0 0 1 3 0 1 1 0
171 Kalpana 1412 26 2 5 1 0 0 0 2 1 2 0 1
172 Tasreen 1806 25 2 5 1 0 0 0 2 0 1 0 0
173 Selvarani 1402 38 4 5 3 2 2 0 3 1 2 0 1
174 Ranjani 13891 24 2 4 1 0 0 0 3 1 1 1 1
175 Sasikala 490 22 2 5 1 0 0 0 1 0 2 0 1
176 Uma 7147 31 3 4 2 0 0 1 3 1 2 1 1
177 Selvakumari 198 22 2 5 1 0 0 0 2 1 2 0 0
178 Vijaya 132 22 2 5 1 0 0 0 2 1 1 0 0
179 Sangeetha 1142 19 1 4 1 0 0 0 3 1 1 1 0
180 Dharani 140 32 3 4 2 1 1 0 2 1 2 0 0
181 Lalitha 1141 21 2 5 1 0 0 0 3 0 1 0 0
182 Vanitha 404 27 2 4 1 0 0 0 3 1 2 1 1
183 Lakshmi 9221 20 1 5 1 0 0 0 2 0 1 0 0
184 Renuka 411 26 2 5 1 0 0 0 3 1 2 0 0
185 Rekha 19670 33 3 5 2 1 1 0 2 1 1 1 0
186 Chitra 1587 19 1 4 1 0 0 0 1 0 2 0 0
187 Kuppammal 386 29 2 5 3 1 1 1 3 0 1 0 0
188 Latha 617 33 3 4 2 1 0 0 3 1 1 1 0
189 Kavitha 379 19 1 4 1 0 0 0 2 1 1 0 0
190 Vathana 377 28 2 5 2 1 1 0 2 1 2 0 1
191 Revathy 293 28 2 4 1 0 0 0 3 0 1 0 0
192 Varalakshmi 362 20 1 5 1 0 0 0 2 1 2 0 0
193 Sasirekha 4019 22 2 5 1 0 0 0 2 1 1 1 1
194 Sathya 4061 37 4 5 3 2 1 0 2 1 2 0 0
195 Ammu 354 20 1 5 1 0 0 0 3 1 1 0 0
196 Latha 344 26 2 5 2 1 1 0 1 0 2 1 0
197 Kala 215 25 2 4 1 0 0 0 3 1 1 1 0
198 Geetha 32 19 1 5 1 0 0 0 2 1 2 0 0
199 Saradha 225 19 1 4 1 0 0 0 2 1 1 0 0
200 Kannammal 863 25 2 5 3 1 1 1 1 0 2 0 1
201 Gowri 487 28 2 5 1 0 0 0 3 1 1 1 0
202 Indumathy 8358 24 2 5 2 1 1 0 2 1 2 0 0
203 Suganya 5233 20 1 4 1 0 0 0 3 1 1 0 1
204 Sriranjini 5255 34 3 4 3 1 1 1 2 1 2 0 0
205 Nandini 4542 23 2 5 1 0 0 0 3 1 1 0 0
206 Muniyammal 5546 24 2 4 1 0 0 0 1 0 2 0 0
207 Petchiammal 634 27 2 5 3 2 1 0 3 1 1 1 0
208 Amulu 436 28 2 4 1 0 0 0 2 1 2 1 1
209 Arokiya Mary 345 22 2 5 1 0 0 0 3 1 1 0 0
210 Vandhana 4523 26 2 5 1 0 0 0 3 1 2 0 0
211 Gowthami 224 24 2 4 1 0 0 0 2 1 1 0 0
212 Fathima 323 26 2 5 2 1 1 0 2 1 2 1 0
213 Meenakshi 4764 36 4 4 3 2 0 0 2 1 1 0 0
214 Shanti 365 18 1 5 1 0 0 0 2 1 2 1 1
215 Shobana 3786 28 2 5 2 1 0 0 2 1 1 0 0
216 Kalamani 4856 28 2 4 3 1 1 1 1 0 2 0 0
217 Lalitha 223 19 1 4 1 0 0 0 2 0 1 0 0
218 Mariammal 886 30 2 5 2 0 0 1 2 0 2 0 0
219 Kuzhandai 457 28 2 5 1 0 0 0 2 1 1 0 0
220 Jenny 345 29 2 5 3 1 0 1 3 1 2 0 1
221 Haritha 10355 26 2 5 2 0 0 1 2 0 1 0 0
222 Thamarai 355 24 2 5 1 0 0 0 2 1 2 1 0
223 Sumathy 14291 27 2 5 2 1 0 0 2 1 1 0 0
224 Thenmozhi 1434 24 2 5 1 0 0 0 2 0 2 0 0
225 Nithya 13414 29 2 4 2 1 1 0 2 1 1 0 0
226 Vigneshwari 5754 20 1 5 1 0 0 0 2 1 2 1 1
227 Vinitha 734 25 2 4 1 0 0 0 1 0 1 1 1
228 Polammal 563 26 2 4 2 1 1 0 2 1 1 0 0
229 Vijaya 445 20 1 5 1 0 0 0 2 1 2 0 0
230 Ramalakshmi 2355 24 2 4 1 0 0 0 2 1 1 1 0
231 Madhu 2545 26 2 4 2 1 1 0 2 1 2 0 0
232 Deepika 454 27 2 5 1 0 0 0 3 1 1 1 0
233 Kiruthika 345 28 2 5 2 1 1 0 2 0 2 0 1
234 Kuruvammal 367 22 2 4 1 0 0 0 3 0 1 0 0
235 Pachaiammal 675 23 2 5 2 1 1 0 2 1 1 1 0
236 Thirumani 575 24 2 5 1 0 0 0 3 1 2 1 0
237 Jaya Mary 577 20 1 5 1 0 0 0 3 1 1 0 1
238 Reeta 10453 36 4 5 3 2 1 0 2 1 2 0 0
239 Deepa 354 27 2 4 2 1 1 0 3 1 2 0 0
240 Yuvrani 646 19 1 4 1 0 0 0 2 1 1 0 0
241 Saranya 235 32 3 4 3 1 1 1 3 1 2 1 1
242 Lakshmi 2451 27 2 5 1 0 0 0 2 1 2 0 0
243 Baby 355 18 1 5 1 0 0 0 3 1 1 0 0
244 Jayashree 10355 19 1 5 1 0 0 0 2 0 1 0 0
245 Kaviya 1535 26 2 4 3 1 1 1 2 0 2 0 0
246 Ramya 543 24 2 5 1 0 0 0 3 1 2 1 0
247 Munira begum 234 20 1 5 1 0 0 0 3 1 1 0 0
248 Jayashree 5748 36 4 5 3 1 1 1 2 0 2 1 0
249 Mithra 346 20 1 4 1 0 0 0 1 1 1 1 0
250 Swetha 457 26 2 5 2 1 0 0 3 0 2 1 0
251 Shivashankari 446 28 2 4 1 0 0 0 2 1 1 1 0
252 Sandhiya 545 33 3 4 2 0 0 1 2 1 2 0 1
253 Deepika 756 27 2 5 1 0 0 0 2 0 1 0 0
254 Swetha 10224 26 2 5 2 0 0 1 3 1 2 0 0
255 Sandhiya 546 19 1 4 1 0 0 0 2 1 1 0 0
256 Sandhiya 234 27 2 4 1 0 0 0 3 1 2 1 1
257 Rathi 354 27 2 5 3 2 2 0 2 0 1 0 0
258 Praveena 358 24 2 4 1 0 0 0 2 1 2 0 0
259 Mathumitha 10435 23 2 5 1 0 0 0 3 1 1 0 0
260 Pongkodi 5445 34 3 5 1 0 0 0 2 1 2 0 0
261 Poornima 2547 38 4 5 3 1 0 1 2 1 1 0 0
262 Nisha 2347 20 1 4 1 0 0 0 2 1 2 0 0
263 Charulatha 645 29 2 5 2 1 1 0 3 1 1 0 0
264 Janani 574 22 2 4 1 0 0 0 2 1 2 0 1
265 Madhumitha 564 36 4 5 2 1 0 0 3 1 1 1 0
266 Santhya 10843 20 1 5 1 0 0 0 2 1 2 0 0
267 Vijayalakshmi 1243 21 2 5 1 0 0 0 3 0 1 0 0
268 Hemavathy 4382 22 2 4 1 0 0 0 2 1 2 1 0
269 Kaviya 645 26 2 5 2 1 0 0 3 1 1 0 0
270 Sahina 4435 37 4 5 3 2 2 0 2 0 2 0 1
271 Abinaya 4657 25 2 5 1 0 0 0 2 1 2 0 0
272 Shahina 763 20 1 5 1 0 0 0 2 1 2 0 0
273 Varsha 654 24 2 4 1 0 0 0 3 1 1 0 0
274 Sarmitha 745 35 3 5 3 1 1 1 2 0 2 0 1
275 Jenifier 773 28 2 4 1 0 0 0 1 0 1 0 0
276 Husha 434 36 4 5 3 0 0 2 1 0 2 0 0
277 Divya 346 24 2 5 1 0 0 0 2 1 1 0 0
278 Deniza 3541 20 1 5 1 0 0 0 3 0 2 1 1
279 Rosiz 1538 24 2 4 1 0 0 0 2 1 1 0 0
280 Vennila 15741 36 4 5 1 0 0 0 2 1 2 0 0
281 Kavitha 10595 23 2 4 1 0 0 0 3 1 2 1 0
282 Sharmila 3436 35 3 5 3 1 1 1 1 0 1 1 0
283 Sujithra 464 29 2 5 2 0 0 1 2 1 2 0 1
284 Megala 546 25 2 4 1 0 0 0 3 0 1 0 1
285 Ayesha begam 978 26 2 5 2 1 1 0 2 1 2 1 1
286 Kalpana 844 19 1 5 1 0 0 0 2 1 1 0 0
287 Vasanthi 687 24 2 4 1 0 0 0 3 1 2 0 0
288 Kavitha 868 32 3 5 2 1 1 0 1 0 2 0 0
289 Asma 467 38 4 5 4 0 0 3 2 1 1 1 1
290 Ebinesan 582 23 2 5 1 0 0 0 2 1 2 0 1
291 Pavitra 435 30 2 4 2 1 1 0 1 0 1 0 0
292 Archana 352 30 2 5 2 1 1 0 2 0 2 0 0
293 Subha latha 2328 26 2 5 1 0 0 0 2 1 2 0 1
294 Satherna 1863 28 2 4 3 2 2 0 2 1 1 0 0
295 Malalthy 12121 32 3 5 2 0 0 1 2 1 2 0 0
296 Furzana 1265 27 2 5 1 0 0 0 2 1 1 1 0
297 Fazila 356 24 2 5 1 0 0 0 1 0 2 1 0
298 Durgadevi 724 33 3 4 3 1 1 1 2 0 2 0 1
299 Vaishnavi 235 26 2 4 1 0 0 0 2 1 1 0 0
300 Esther 10283 36 4 5 2 1 1 0 1 0 1 0 0
301 Sanjana 1284 28 2 5 2 1 0 0 2 1 1 1 0
302 Nanthitha 1082 31 3 4 1 0 0 0 2 1 2 1 0
303 Yamini 1246 32 3 3 2 1 1 0 3 0 2 0 1
304 Hemavathy 1234 32 3 4 2 1 1 0 2 1 2 0 0
305 Reshma 12354 27 2 5 1 0 0 0 1 0 1 0 0
306 Valarmathy 375 28 2 4 2 1 0 0 2 1 1 0 0
307 Yuvashree 3588 23 2 5 1 0 0 0 3 1 2 1 1
308 Ramya 478 33 3 5 3 2 2 0 2 1 1 1 0
309 Santhiya 436 38 4 5 4 1 1 2 2 0 2 1 0
310 Pavithra 3664 22 2 4 1 0 0 0 2 1 2 0 0
  
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 

